Related Experiment Video
Updated: Jan 19, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
Nuclear action of FGF members in endocrine-related tissues and cancer: Interplay with steroid receptor pathways
Virginia Figueroa1, María Sol Rodríguez1, Claudia Lanari1
1Instituto de Biología y Medicina Experimental (IBYME-CONICET), Vuelta de Obligado 2490, Buenos Aires 1428, Argentina.
Abstract:
Dysregulation of the fibroblast growth factors/fibroblast growth factor receptor (FGF/FGFR) pathway has been implicated in a wide range of human disorders and several members have been localized in the nuclear compartment. Hormone-activated steroid receptors or ligand independent activated receptors form nuclear complexes that activate gene transcription. This review aims to highlight the interplay between the steroid receptor and the FGF/FGFR pathways and focuses on the current knowledge on nuclear action of FGF members in endocrine-related tissues and cancer. The nuclear trafficking and targets of FGF/FGFR members and the available evidence on the interplay with steroid hormones and receptors is described. Finally, the data on aberrant FGF/FGFR signaling is summarized and the nuclear action of FGF members on endocrine resistant breast cancer is highlighted. Identifying the mechanisms underlying FGF-induced endocrine resistance will be important to understand how to efficiently target endocrine-related diseases and even enhance or restore endocrine sensitivity in hormone receptor positive tumors.
Insights
Fibroblast growth factor (FGF) signaling impacts nuclear functions, influencing steroid receptors and gene transcription. Understanding FGF/FGFR nuclear actions is key to targeting endocrine-related diseases and breast cancer.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Dysregulation of fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) signaling is linked to various human disorders.
- Several FGF members are found in the nuclear compartment, suggesting roles beyond cell surface signaling.
- Steroid receptors form nuclear complexes to activate gene transcription upon hormone binding or ligand-independent activation.
Purpose of the Study:
- To review the interplay between steroid receptor and FGF/FGFR pathways.
- To summarize current knowledge on the nuclear actions of FGF members in endocrine tissues and cancer.
- To highlight the role of nuclear FGF/FGFR signaling in endocrine-resistant breast cancer.
Main Methods:
- Literature review focusing on nuclear trafficking and targets of FGF/FGFR members.
- Analysis of evidence detailing the interplay between FGF/FGFR and steroid hormones/receptors.
- Summary of data on aberrant FGF/FGFR signaling and its nuclear effects.
Main Results:
- FGF/FGFR members exhibit nuclear localization and interact with steroid hormone pathways.
- Nuclear FGF/FGFR signaling influences gene transcription, particularly in endocrine-related tissues.
- Aberrant FGF/FGFR signaling contributes to endocrine resistance in breast cancer.
Conclusions:
- Understanding the nuclear functions of FGF/FGFR is crucial for developing targeted therapies.
- Investigating FGF-induced endocrine resistance mechanisms can improve treatment strategies for hormone receptor-positive tumors.
- Targeting nuclear FGF/FGFR actions may enhance or restore endocrine sensitivity in endocrine-related diseases.
Related Concept Videos
Endocrine Signaling
11:07Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
04:14In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
07:48Working with Human Tissues for Translational Cancer Research
Insulin: The Receptor and Signaling Pathways
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
